Exp Mol Med.  2006 Jun;38(3):325-331.

Role of p21CIP1 as a determinant of SC-560 response in human HCT116 colon carcinoma cells

Affiliations
  • 1Department of Bioscience and Biotechnology, Sejong University, Seoul 143-747, Korea. sjlim@sejong.ac.kr
  • 2Research Institute National Cancer Center, Goyang, Gyeonggi-do 410-769, Korea.
  • 3Department of Physiology and Biophysics, Inha University, College of Medicine, Incheon 402-751, Korea.

Abstract

SC-560, a strucutral analogue of celecoxib, induces growth inhibition in a wide range of human cancer cells in a cyclooxygenase (COX)-independent manner. Since SC-560 suppresses the growth of cancer cells mainly by inducing cell cycle arrest, we sought to examine the role of p21CIP1, a cell cycle regulator protein, in the cellular response against SC-560 by using p21(+/+)and p21(-/-)isogenic HCT116 colon carcinoma cells. In HCT116 (p21(+/+)) cells, SC-560 dose-dependently induced growth inhibition and cell cycle arrest at the G1 phase without significant apoptosis induction. SC-560-induced cell cycle arrest was accompanied by upregulation of p21CIP1. However, the extent of SC-560-induced accumulation at the G1 phase was approximately equal in the p21(+/+)and the p21(-/-)cells. Nonetheless, the growth inhibition by SC-560 was increased in p21(-/-)cells than p21(+/+)cells. SC-560-induced reactive oxygen species (ROS) generation did not differ between p21(+/+)and p21(-/-)cells but the subsequent activaton of apoptotic caspase cascade was more pronounced in p21(-/-)cells compared with p21(+/+)cells. These results suggest that p21CIP1 blocks the SC-560-induced apoptotic response of HCT116 cells. SC-560 combined with other therapy that can block p21 CIP1 expression or function may contribute to the effective treatment of colon cancer.

Keyword

apoptosis; caspase; cell cycle; cyclin-dependent kinase inhibitor p21; growth inhibitors; HCT116 cells; SC 560

MeSH Terms

Reactive Oxygen Species/metabolism
Pyrazoles/*pharmacology
Mutation
Immunoblotting
Humans
HCT116 Cells
Genotype
Flow Cytometry
Dose-Response Relationship, Drug
Cyclooxygenase Inhibitors/pharmacology
Cyclin-Dependent Kinase Inhibitor p21/genetics/metabolism/*physiology
Colonic Neoplasms/genetics/metabolism/pathology
Cell Survival/drug effects
Cell Proliferation/drug effects
Cell Differentiation/drug effects
Cell Cycle Proteins/metabolism
Cell Cycle/drug effects
Apoptosis/drug effects
Antineoplastic Agents/pharmacology
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr